CD274 and cancer: In addition, in a recent clinical trial, combinatorial therapy using nivolumab and statin improved NSCLC survival rates; however, information regarding the functions of ATO in immune checkpoint regulation in cancer or EV PD-L1-mediated immune regulation is scanty.